Literature DB >> 16199631

Routine ultrasonography compared with maternal serum alpha-fetoprotein for neural tube defect screening.

Carol T Norem1, Edgar J Schoen, David L Walton, Robyn C Krieger, Jennifer O'Keefe, Trinh T To, G Thomas Ray.   

Abstract

OBJECTIVE: This study was done to estimate the value of prenatal maternal serum alpha-fetoprotein (MSAFP) screening compared with that of routine ultrasonography in the diagnosis of neural tube defects (NTDs).
METHODS: An integrated database was used retrospectively to identify cases of NTDs among 219,000 consecutive pregnancy outcomes observed during a 7-year period at 40 Kaiser Permanente facilities in Northern California. We specifically examined types of NTD and the tests used to diagnose cases.
RESULTS: We identified 189 NTD cases, 102 of which had received MSAFP screening. Results of MSAFP testing were negative in 25 (25%) of these 102 cases. Without other testing, these 25 NTD diagnoses would have been missed. These included 15 (38%) of the 40 spina bifida cases screened, 6 (67%) of the 9 encephalocele cases screened, and 4 (8%) of the 53 anencephaly cases screened. Of the 186 NTD cases diagnosed prenatally, 115 (62%) were initially detected by routine ultrasonography administered during the second trimester without knowledge of MSAFP values; 69 (37%) were diagnosed by targeted ultrasonography after MSAFP screening indicated a higher risk for NTD; and 2 (1%) were diagnosed by pathology examination after miscarriage.
CONCLUSION: Compared with MSAFP performed alone for screening, routine second-trimester ultrasonography was more likely to discover an NTD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16199631     DOI: 10.1097/01.AOG.0000178780.63956.3b

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  9 in total

1.  Prenatal testing for Down syndrome: comparison of screening practices in the UK and USA.

Authors:  Dagmar Tapon
Journal:  J Genet Couns       Date:  2009-11-03       Impact factor: 2.537

Review 2.  Prenatal diagnosis of spina bifida: from intracranial translucency to intrauterine surgery.

Authors:  Waldo Sepulveda; Amy E Wong; Francisco Sepulveda; Juan L Alcalde; Juan C Devoto; Felipe Otayza
Journal:  Childs Nerv Syst       Date:  2017-06-07       Impact factor: 1.475

3.  Long-term follow-up for keystone design perforator island flap for closure of myelomeningocele.

Authors:  Christopher Donaldson; Hamsaveni K M Murday; Matthew J Gutman; Rory Maher; Tony Goldschlager; Chris Xenos; R Andrew Danks
Journal:  Childs Nerv Syst       Date:  2017-12-18       Impact factor: 1.475

Review 4.  Neural tube defects: from a proteomic standpoint.

Authors:  Tania M Puvirajesinghe; Jean-Paul Borg
Journal:  Metabolites       Date:  2015-03-17

5.  Perinatal and Neonatal Outcomes of Patients Who Were Diagnosed with Neural Tube Defect in Midtrimester Fetal Ultrasound Scan and Refused Request for Termination of Pregnancy.

Authors:  Rauf Melekoglu; Sevil Eraslan; Ebru Celik; Yavuz Simsek
Journal:  Biomed Res Int       Date:  2016-11-23       Impact factor: 3.411

6.  Genome wide noninvasive prenatal testing detects microduplication of the distal end of chromosome 15 in a fetus: a case report.

Authors:  Hana Sahinbegovic; Stephanie Andres; Sabine Langer-Freitag; Aspasia Divane; Fotini Ieremiadou; Senad Mehmedbasic; Aida Catic
Journal:  Mol Cytogenet       Date:  2022-04-02       Impact factor: 2.009

7.  Serum exosomal coronin 1A and dynamin 2 as neural tube defect biomarkers.

Authors:  Yanfu Wang; Ling Ma; Shanshan Jia; Dan Liu; Hui Gu; Xiaowei Wei; Wei Ma; Wenting Luo; Yuzuo Bai; Weilin Wang; Zhengwei Yuan
Journal:  J Mol Med (Berl)       Date:  2022-08-01       Impact factor: 5.606

8.  Detection of neural tube defect in the first and second trimester of pregnancy by ultrasound in Imam Hospital, Ahwaz between December 2008-2010.

Authors:  Sara Masihi; Mojgan Barati; Javad Marfu; Zahra Eskandari
Journal:  Iran J Reprod Med       Date:  2012-11

9.  SELDI-TOF-MS proteomic profiling of serum, urine, and amniotic fluid in neural tube defects.

Authors:  Zhenjiang Liu; Zhengwei Yuan; Qun Zhao
Journal:  PLoS One       Date:  2014-07-23       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.